
Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT
Keywords: CDDP, Cisplatin; Par-4, prostate apoptosis response-4; PI3K/Akt; EMT, Epithelial to mesenchymal transition; Pancreatic cancer